Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296:1635–1636
PubMed
Article
CAS
Google Scholar
Ogasawara J, Watanabe-Fukunaga R, Adachi M et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:806–809
PubMed
Article
CAS
Google Scholar
Garcia-Fuster MJ, Ferrer-Alcon M, Miralles A, Garcia-Sevilla JA (2004) Deglycosylation of Fas receptor and chronic morphine treatment up-regulate high molecular mass Fas aggregates in the rat brain. Eur J Pharmacol 496:63–69
PubMed
Article
CAS
Google Scholar
Cui H, Ju ST, Sherr DH (1996) Functional expression of Fas (CD95) protein in autoimmune lpr mice. Cell Immunol 174:35–41
PubMed
Article
CAS
Google Scholar
Kobayashi S, Hirano T, Kakinuma M, Uede T (1993) Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem Biophys Res Commun 191:617–624
PubMed
Article
CAS
Google Scholar
Adachi M, Suematsu S, Kondo T et al (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11:294–300
PubMed
Article
CAS
Google Scholar
Drappa J, Brot N, Elkon KB (1993) The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci USA 90:10340–10344
PubMed
Article
CAS
Google Scholar
Strater J, Walczak H, Hasel C, Melzner I, Leithauser F, Moller P (2001) CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies. Cell Death Differ 8:273–278
PubMed
Article
CAS
Google Scholar